Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024
07 August 2024 - 6:01AM
Journey Medical Corporation (“Journey Medical” or the “Company”)
(Nasdaq: DERM), a commercial-stage pharmaceutical company that
primarily focuses on selling and marketing FDA-approved
prescription pharmaceutical products for the treatment of
dermatological conditions, today announced the Company will release
its second quarter 2024 financial results after the U.S. financial
markets close on Monday, August 12, 2024. Journey Medical
management will conduct a conference call and audio webcast on
Monday, August 12, 2024 at 4:30 p.m. ET.
To listen to the conference call, interested
parties within the U.S. should dial 1-866-777-2509 (domestic) or
1-412-317-5413 (international). All callers should dial in
approximately 10 minutes prior to the scheduled start time and ask
to join the Journey Medical conference call. Participants can
register for the conference by navigating to
https://dpregister.com/sreg/10190841/fd0fed9bae. Please note that
registered participants will receive their dial-in number upon
registration.
A live audio webcast can be accessed on the News
and Events page of the Investors section of Journey Medical’s
website, www.journeymedicalcorp.com, and will remain available for
replay for approximately 30 days after the conference call.
About Journey Medical
CorporationJourney Medical Corporation (Nasdaq: DERM)
(“Journey Medical”) is a commercial-stage pharmaceutical company
that primarily focuses on selling and marketing FDA-approved
prescription pharmaceutical products for the treatment of
dermatological conditions through its efficient sales and marketing
model. The company currently markets seven branded and two generic
products that help treat and heal common skin conditions. The
Journey Medical team comprises industry experts with extensive
experience in developing and commercializing some of dermatology’s
most successful prescription brands. Journey Medical is located in
Scottsdale, Arizona and was founded by Fortress Biotech, Inc.
(Nasdaq: FBIO). Journey Medical’s common stock is registered under
the Securities Exchange Act of 1934, as amended, and it files
periodic reports with the U.S. Securities and Exchange Commission
(“SEC”). For additional information about Journey Medical, visit
www.journeymedicalcorp.com.
Company Contact:Jaclyn Jaffe
Journey Medical Corporation(781) 652-4500ir@jmcderm.com
Media Relations Contact:Tony
Plohoros6 Degrees(908) 591-2839tplohoros@6degreespr.com
Journey Medical (NASDAQ:DERM)
Historical Stock Chart
From Jul 2024 to Aug 2024
Journey Medical (NASDAQ:DERM)
Historical Stock Chart
From Aug 2023 to Aug 2024